INSMED INC Deferred Tax Assets, Operating Loss Carryforwards
INSMED INC (INSM) had Deferred Tax Assets, Operating Loss Carryforwards of $956.03 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $956.03M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $672.74M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $563.87M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $499.03M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $956.03M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $672.74M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $563.87M 10-K · filed 2025-02-20 | |
| 2022-12-31 | $499.03M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $471.41M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $377.09M 10-K · filed 2022-02-17 | |
| 2019-12-31 | $304.27M 10-K · filed 2021-02-25 | $300.29M 10-K · filed 2020-02-25 |
| 2018-12-31 | $231.92M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $186.34M 10-K · filed 2019-02-22 | |
| 2016-12-31 | $228.73M 10-K · filed 2018-02-23 | |
| 2015-12-31 | $195.05M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $160.76M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $149.75M 10-K · filed 2015-02-27 | |
| 2012-12-31 | $128.26M 10-K · filed 2014-03-06 | |
| 2011-12-31 | $119.72M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |